As reviewed before [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40], BPC 157s g-ng dose range applied alone, without carrier addition, and its application including via the per oral route, clinical evidence, and toxicology without LD1 can ascertain its practical applicability
Bayside predicted on December 16 that tirzepatide is 80% likely to come off shortage this week, which proved true, and asserted, I think there is a 50% chance the same thing happens with semaglutide, either this week or next. After the tirzepatide decision, they raised their estimate to 80%
The goal is to get the peptide as close to the target tissue as possible, since BPC-157 acts primarily locally
(Study: Wadden et al., 2021) AOD 9604 Peptide AOD 9604 is a synthetic peptide designed to promote weight loss by mimicking the action of natural human growth hormone (hGH)
Probiotics : While not always present, probiotics, when included, could support gut health, which might have a general benefit on digestion and nutrient absorption